ArticleClinical medicine insights. Arthritis and musculoskeletal disorders2026
Interleukin-6 as a Marker of Joint Damage in Osteoarthritis: A Study of Its Pro-inflammatory Impacts.
Dwitya Elvira et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.